nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—ABCB1—Methylprednisolone—psoriatic arthritis	0.0719	0.279	CbGbCtD
Alitretinoin—ABCB1—Betamethasone—psoriatic arthritis	0.0467	0.182	CbGbCtD
Alitretinoin—ABCB1—Prednisolone—psoriatic arthritis	0.0461	0.179	CbGbCtD
Alitretinoin—ABCB1—Prednisone—psoriatic arthritis	0.0435	0.169	CbGbCtD
Alitretinoin—ABCB1—Dexamethasone—psoriatic arthritis	0.0272	0.106	CbGbCtD
Alitretinoin—ABCB1—Methotrexate—psoriatic arthritis	0.0218	0.0849	CbGbCtD
Alitretinoin—CRABP1—skin of body—psoriatic arthritis	0.00107	0.148	CbGeAlD
Alitretinoin—CRABP2—skin of body—psoriatic arthritis	0.000971	0.134	CbGeAlD
Alitretinoin—CRABP1—tendon—psoriatic arthritis	0.000817	0.112	CbGeAlD
Alitretinoin—CRABP2—tendon—psoriatic arthritis	0.000739	0.102	CbGeAlD
Alitretinoin—RARG—skin of body—psoriatic arthritis	0.000708	0.0974	CbGeAlD
Alitretinoin—RARB—tendon—psoriatic arthritis	0.000661	0.0909	CbGeAlD
Alitretinoin—RXRG—tendon—psoriatic arthritis	0.000646	0.0889	CbGeAlD
Alitretinoin—RXRB—tendon—psoriatic arthritis	0.000607	0.0835	CbGeAlD
Alitretinoin—RARG—tendon—psoriatic arthritis	0.000539	0.0742	CbGeAlD
Alitretinoin—RARA—tendon—psoriatic arthritis	0.000507	0.0697	CbGeAlD
Alitretinoin—Sweating—Methotrexate—psoriatic arthritis	0.000324	0.00044	CcSEcCtD
Alitretinoin—Infection—Methylprednisolone—psoriatic arthritis	0.000323	0.000439	CcSEcCtD
Alitretinoin—Haematuria—Methotrexate—psoriatic arthritis	0.000322	0.000438	CcSEcCtD
Alitretinoin—Shock—Triamcinolone—psoriatic arthritis	0.000321	0.000436	CcSEcCtD
Alitretinoin—Insomnia—Prednisolone—psoriatic arthritis	0.000321	0.000436	CcSEcCtD
Alitretinoin—Alopecia—Prednisone—psoriatic arthritis	0.00032	0.000436	CcSEcCtD
Alitretinoin—Shock—Methylprednisolone—psoriatic arthritis	0.00032	0.000435	CcSEcCtD
Alitretinoin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000319	0.000434	CcSEcCtD
Alitretinoin—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000319	0.000433	CcSEcCtD
Alitretinoin—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000319	0.000433	CcSEcCtD
Alitretinoin—Epistaxis—Methotrexate—psoriatic arthritis	0.000318	0.000433	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisolone—psoriatic arthritis	0.000318	0.000433	CcSEcCtD
Alitretinoin—Tachycardia—Triamcinolone—psoriatic arthritis	0.000318	0.000433	CcSEcCtD
Alitretinoin—Mental disorder—Prednisone—psoriatic arthritis	0.000318	0.000432	CcSEcCtD
Alitretinoin—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000318	0.000432	CcSEcCtD
Alitretinoin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000316	0.00043	CcSEcCtD
Alitretinoin—Erythema—Prednisone—psoriatic arthritis	0.000316	0.000429	CcSEcCtD
Alitretinoin—Malnutrition—Prednisone—psoriatic arthritis	0.000316	0.000429	CcSEcCtD
Alitretinoin—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000315	0.000429	CcSEcCtD
Alitretinoin—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000315	0.000428	CcSEcCtD
Alitretinoin—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000315	0.000428	CcSEcCtD
Alitretinoin—Convulsion—Dexamethasone—psoriatic arthritis	0.000314	0.000427	CcSEcCtD
Alitretinoin—Convulsion—Betamethasone—psoriatic arthritis	0.000314	0.000427	CcSEcCtD
Alitretinoin—Hypertension—Dexamethasone—psoriatic arthritis	0.000313	0.000426	CcSEcCtD
Alitretinoin—Hypertension—Betamethasone—psoriatic arthritis	0.000313	0.000426	CcSEcCtD
Alitretinoin—Myalgia—Dexamethasone—psoriatic arthritis	0.000309	0.00042	CcSEcCtD
Alitretinoin—Myalgia—Betamethasone—psoriatic arthritis	0.000309	0.00042	CcSEcCtD
Alitretinoin—Anxiety—Betamethasone—psoriatic arthritis	0.000308	0.000418	CcSEcCtD
Alitretinoin—Anxiety—Dexamethasone—psoriatic arthritis	0.000308	0.000418	CcSEcCtD
Alitretinoin—Discomfort—Betamethasone—psoriatic arthritis	0.000305	0.000415	CcSEcCtD
Alitretinoin—Discomfort—Dexamethasone—psoriatic arthritis	0.000305	0.000415	CcSEcCtD
Alitretinoin—Haemoglobin—Methotrexate—psoriatic arthritis	0.000305	0.000414	CcSEcCtD
Alitretinoin—Hypotension—Methylprednisolone—psoriatic arthritis	0.000304	0.000413	CcSEcCtD
Alitretinoin—Pain—Prednisolone—psoriatic arthritis	0.000303	0.000412	CcSEcCtD
Alitretinoin—Haemorrhage—Methotrexate—psoriatic arthritis	0.000303	0.000412	CcSEcCtD
Alitretinoin—Hepatitis—Methotrexate—psoriatic arthritis	0.000303	0.000412	CcSEcCtD
Alitretinoin—Pharyngitis—Methotrexate—psoriatic arthritis	0.000301	0.000409	CcSEcCtD
Alitretinoin—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000299	0.000407	CcSEcCtD
Alitretinoin—Vision blurred—Prednisone—psoriatic arthritis	0.000298	0.000405	CcSEcCtD
Alitretinoin—Urethral disorder—Methotrexate—psoriatic arthritis	0.000297	0.000404	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000297	0.000404	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000296	0.000403	CcSEcCtD
Alitretinoin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000296	0.000402	CcSEcCtD
Alitretinoin—Oedema—Betamethasone—psoriatic arthritis	0.000296	0.000402	CcSEcCtD
Alitretinoin—Oedema—Dexamethasone—psoriatic arthritis	0.000296	0.000402	CcSEcCtD
Alitretinoin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000296	0.000402	CcSEcCtD
Alitretinoin—Insomnia—Triamcinolone—psoriatic arthritis	0.000295	0.000401	CcSEcCtD
Alitretinoin—Insomnia—Methylprednisolone—psoriatic arthritis	0.000294	0.0004	CcSEcCtD
Alitretinoin—Infection—Dexamethasone—psoriatic arthritis	0.000294	0.0004	CcSEcCtD
Alitretinoin—Infection—Betamethasone—psoriatic arthritis	0.000294	0.0004	CcSEcCtD
Alitretinoin—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000293	0.000398	CcSEcCtD
Alitretinoin—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000293	0.000398	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000292	0.000397	CcSEcCtD
Alitretinoin—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000292	0.000397	CcSEcCtD
Alitretinoin—Visual impairment—Methotrexate—psoriatic arthritis	0.000292	0.000397	CcSEcCtD
Alitretinoin—Anaemia—Prednisone—psoriatic arthritis	0.000292	0.000397	CcSEcCtD
Alitretinoin—Shock—Dexamethasone—psoriatic arthritis	0.000291	0.000396	CcSEcCtD
Alitretinoin—Shock—Betamethasone—psoriatic arthritis	0.000291	0.000396	CcSEcCtD
Alitretinoin—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000291	0.000395	CcSEcCtD
Alitretinoin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00029	0.000394	CcSEcCtD
Alitretinoin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00029	0.000394	CcSEcCtD
Alitretinoin—Agitation—Prednisone—psoriatic arthritis	0.00029	0.000394	CcSEcCtD
Alitretinoin—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00029	0.000394	CcSEcCtD
Alitretinoin—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00029	0.000394	CcSEcCtD
Alitretinoin—Tachycardia—Dexamethasone—psoriatic arthritis	0.000289	0.000393	CcSEcCtD
Alitretinoin—Tachycardia—Betamethasone—psoriatic arthritis	0.000289	0.000393	CcSEcCtD
Alitretinoin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000287	0.00039	CcSEcCtD
Alitretinoin—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000287	0.00039	CcSEcCtD
Alitretinoin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000286	0.000389	CcSEcCtD
Alitretinoin—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000286	0.000389	CcSEcCtD
Alitretinoin—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000286	0.000389	CcSEcCtD
Alitretinoin—Malaise—Prednisone—psoriatic arthritis	0.000285	0.000387	CcSEcCtD
Alitretinoin—Eye disorder—Methotrexate—psoriatic arthritis	0.000283	0.000385	CcSEcCtD
Alitretinoin—Syncope—Prednisone—psoriatic arthritis	0.000283	0.000385	CcSEcCtD
Alitretinoin—Tinnitus—Methotrexate—psoriatic arthritis	0.000283	0.000384	CcSEcCtD
Alitretinoin—Anorexia—Dexamethasone—psoriatic arthritis	0.000282	0.000383	CcSEcCtD
Alitretinoin—Anorexia—Betamethasone—psoriatic arthritis	0.000282	0.000383	CcSEcCtD
Alitretinoin—Urticaria—Prednisolone—psoriatic arthritis	0.000282	0.000383	CcSEcCtD
Alitretinoin—Fatigue—Triamcinolone—psoriatic arthritis	0.000281	0.000382	CcSEcCtD
Alitretinoin—Fatigue—Methylprednisolone—psoriatic arthritis	0.00028	0.000381	CcSEcCtD
Alitretinoin—Pain—Triamcinolone—psoriatic arthritis	0.000279	0.000379	CcSEcCtD
Alitretinoin—Loss of consciousness—Prednisone—psoriatic arthritis	0.000277	0.000377	CcSEcCtD
Alitretinoin—Hypotension—Betamethasone—psoriatic arthritis	0.000276	0.000376	CcSEcCtD
Alitretinoin—Hypotension—Dexamethasone—psoriatic arthritis	0.000276	0.000376	CcSEcCtD
Alitretinoin—Angiopathy—Methotrexate—psoriatic arthritis	0.000275	0.000374	CcSEcCtD
Alitretinoin—Convulsion—Prednisone—psoriatic arthritis	0.000274	0.000372	CcSEcCtD
Alitretinoin—Hypertension—Prednisone—psoriatic arthritis	0.000273	0.000371	CcSEcCtD
Alitretinoin—Chills—Methotrexate—psoriatic arthritis	0.000272	0.00037	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00027	0.000366	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00027	0.000366	CcSEcCtD
Alitretinoin—Myalgia—Prednisone—psoriatic arthritis	0.000269	0.000365	CcSEcCtD
Alitretinoin—Arthralgia—Prednisone—psoriatic arthritis	0.000269	0.000365	CcSEcCtD
Alitretinoin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000269	0.000365	CcSEcCtD
Alitretinoin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000268	0.000365	CcSEcCtD
Alitretinoin—Anxiety—Prednisone—psoriatic arthritis	0.000268	0.000364	CcSEcCtD
Alitretinoin—Alopecia—Methotrexate—psoriatic arthritis	0.000268	0.000364	CcSEcCtD
Alitretinoin—Insomnia—Dexamethasone—psoriatic arthritis	0.000268	0.000364	CcSEcCtD
Alitretinoin—Insomnia—Betamethasone—psoriatic arthritis	0.000268	0.000364	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000267	0.000363	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000266	0.000362	CcSEcCtD
Alitretinoin—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000266	0.000361	CcSEcCtD
Alitretinoin—Paraesthesia—Betamethasone—psoriatic arthritis	0.000266	0.000361	CcSEcCtD
Alitretinoin—Discomfort—Prednisone—psoriatic arthritis	0.000266	0.000361	CcSEcCtD
Alitretinoin—Mental disorder—Methotrexate—psoriatic arthritis	0.000266	0.000361	CcSEcCtD
Alitretinoin—Erythema—Methotrexate—psoriatic arthritis	0.000264	0.000359	CcSEcCtD
Alitretinoin—Malnutrition—Methotrexate—psoriatic arthritis	0.000264	0.000359	CcSEcCtD
Alitretinoin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000261	0.000355	CcSEcCtD
Alitretinoin—Dyspepsia—Betamethasone—psoriatic arthritis	0.00026	0.000354	CcSEcCtD
Alitretinoin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00026	0.000354	CcSEcCtD
Alitretinoin—Urticaria—Triamcinolone—psoriatic arthritis	0.000259	0.000352	CcSEcCtD
Alitretinoin—Urticaria—Methylprednisolone—psoriatic arthritis	0.000258	0.000351	CcSEcCtD
Alitretinoin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000258	0.00035	CcSEcCtD
Alitretinoin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000258	0.00035	CcSEcCtD
Alitretinoin—Oedema—Prednisone—psoriatic arthritis	0.000258	0.00035	CcSEcCtD
Alitretinoin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000257	0.00035	CcSEcCtD
Alitretinoin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000257	0.00035	CcSEcCtD
Alitretinoin—Decreased appetite—Betamethasone—psoriatic arthritis	0.000257	0.00035	CcSEcCtD
Alitretinoin—Infection—Prednisone—psoriatic arthritis	0.000256	0.000348	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000255	0.000347	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000255	0.000347	CcSEcCtD
Alitretinoin—Back pain—Methotrexate—psoriatic arthritis	0.000255	0.000347	CcSEcCtD
Alitretinoin—Fatigue—Betamethasone—psoriatic arthritis	0.000255	0.000347	CcSEcCtD
Alitretinoin—Fatigue—Dexamethasone—psoriatic arthritis	0.000255	0.000347	CcSEcCtD
Alitretinoin—Shock—Prednisone—psoriatic arthritis	0.000253	0.000345	CcSEcCtD
Alitretinoin—Pain—Betamethasone—psoriatic arthritis	0.000253	0.000344	CcSEcCtD
Alitretinoin—Pain—Dexamethasone—psoriatic arthritis	0.000253	0.000344	CcSEcCtD
Alitretinoin—Nervous system disorder—Prednisone—psoriatic arthritis	0.000253	0.000344	CcSEcCtD
Alitretinoin—Tachycardia—Prednisone—psoriatic arthritis	0.000251	0.000342	CcSEcCtD
Alitretinoin—Skin disorder—Prednisone—psoriatic arthritis	0.00025	0.00034	CcSEcCtD
Alitretinoin—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000249	0.000339	CcSEcCtD
Alitretinoin—Vision blurred—Methotrexate—psoriatic arthritis	0.000249	0.000338	CcSEcCtD
Alitretinoin—Anorexia—Prednisone—psoriatic arthritis	0.000246	0.000334	CcSEcCtD
Alitretinoin—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000245	0.000333	CcSEcCtD
Alitretinoin—Anaemia—Methotrexate—psoriatic arthritis	0.000244	0.000332	CcSEcCtD
Alitretinoin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000244	0.000331	CcSEcCtD
Alitretinoin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000244	0.000331	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000242	0.000329	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000242	0.000329	CcSEcCtD
Alitretinoin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00024	0.000327	CcSEcCtD
Alitretinoin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00024	0.000326	CcSEcCtD
Alitretinoin—Malaise—Methotrexate—psoriatic arthritis	0.000238	0.000323	CcSEcCtD
Alitretinoin—Urticaria—Betamethasone—psoriatic arthritis	0.000235	0.00032	CcSEcCtD
Alitretinoin—Urticaria—Dexamethasone—psoriatic arthritis	0.000235	0.00032	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000235	0.000319	CcSEcCtD
Alitretinoin—Dizziness—Prednisolone—psoriatic arthritis	0.000234	0.000319	CcSEcCtD
Alitretinoin—Asthenia—Triamcinolone—psoriatic arthritis	0.000234	0.000318	CcSEcCtD
Alitretinoin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000234	0.000318	CcSEcCtD
Alitretinoin—Body temperature increased—Betamethasone—psoriatic arthritis	0.000234	0.000318	CcSEcCtD
Alitretinoin—Abdominal pain—Betamethasone—psoriatic arthritis	0.000234	0.000318	CcSEcCtD
Alitretinoin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000234	0.000318	CcSEcCtD
Alitretinoin—Asthenia—Methylprednisolone—psoriatic arthritis	0.000233	0.000317	CcSEcCtD
Alitretinoin—Insomnia—Prednisone—psoriatic arthritis	0.000233	0.000317	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisone—psoriatic arthritis	0.000231	0.000315	CcSEcCtD
Alitretinoin—Pruritus—Triamcinolone—psoriatic arthritis	0.000231	0.000314	CcSEcCtD
Alitretinoin—Cough—Methotrexate—psoriatic arthritis	0.00023	0.000313	CcSEcCtD
Alitretinoin—Pruritus—Methylprednisolone—psoriatic arthritis	0.00023	0.000313	CcSEcCtD
Alitretinoin—Convulsion—Methotrexate—psoriatic arthritis	0.000229	0.000311	CcSEcCtD
Alitretinoin—Dyspepsia—Prednisone—psoriatic arthritis	0.000227	0.000308	CcSEcCtD
Alitretinoin—Myalgia—Methotrexate—psoriatic arthritis	0.000225	0.000305	CcSEcCtD
Alitretinoin—Arthralgia—Methotrexate—psoriatic arthritis	0.000225	0.000305	CcSEcCtD
Alitretinoin—Chest pain—Methotrexate—psoriatic arthritis	0.000225	0.000305	CcSEcCtD
Alitretinoin—Decreased appetite—Prednisone—psoriatic arthritis	0.000224	0.000305	CcSEcCtD
Alitretinoin—Rash—Prednisolone—psoriatic arthritis	0.000224	0.000304	CcSEcCtD
Alitretinoin—Dermatitis—Prednisolone—psoriatic arthritis	0.000223	0.000304	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000223	0.000303	CcSEcCtD
Alitretinoin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000223	0.000303	CcSEcCtD
Alitretinoin—Fatigue—Prednisone—psoriatic arthritis	0.000222	0.000302	CcSEcCtD
Alitretinoin—Headache—Prednisolone—psoriatic arthritis	0.000222	0.000302	CcSEcCtD
Alitretinoin—Discomfort—Methotrexate—psoriatic arthritis	0.000222	0.000302	CcSEcCtD
Alitretinoin—Constipation—Prednisone—psoriatic arthritis	0.00022	0.0003	CcSEcCtD
Alitretinoin—Confusional state—Methotrexate—psoriatic arthritis	0.000217	0.000295	CcSEcCtD
Alitretinoin—Dizziness—Triamcinolone—psoriatic arthritis	0.000216	0.000293	CcSEcCtD
Alitretinoin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000215	0.000293	CcSEcCtD
Alitretinoin—Dizziness—Methylprednisolone—psoriatic arthritis	0.000215	0.000293	CcSEcCtD
Alitretinoin—Infection—Methotrexate—psoriatic arthritis	0.000214	0.000291	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisone—psoriatic arthritis	0.000212	0.000289	CcSEcCtD
Alitretinoin—Asthenia—Betamethasone—psoriatic arthritis	0.000212	0.000289	CcSEcCtD
Alitretinoin—Asthenia—Dexamethasone—psoriatic arthritis	0.000212	0.000289	CcSEcCtD
Alitretinoin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000211	0.000287	CcSEcCtD
Alitretinoin—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000211	0.000287	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000211	0.000286	CcSEcCtD
Alitretinoin—Nausea—Prednisolone—psoriatic arthritis	0.000211	0.000286	CcSEcCtD
Alitretinoin—Pruritus—Dexamethasone—psoriatic arthritis	0.000209	0.000285	CcSEcCtD
Alitretinoin—Pruritus—Betamethasone—psoriatic arthritis	0.000209	0.000285	CcSEcCtD
Alitretinoin—Skin disorder—Methotrexate—psoriatic arthritis	0.000209	0.000284	CcSEcCtD
Alitretinoin—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000208	0.000283	CcSEcCtD
Alitretinoin—Vomiting—Triamcinolone—psoriatic arthritis	0.000207	0.000282	CcSEcCtD
Alitretinoin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000207	0.000281	CcSEcCtD
Alitretinoin—Rash—Triamcinolone—psoriatic arthritis	0.000206	0.00028	CcSEcCtD
Alitretinoin—Dermatitis—Triamcinolone—psoriatic arthritis	0.000205	0.000279	CcSEcCtD
Alitretinoin—Anorexia—Methotrexate—psoriatic arthritis	0.000205	0.000279	CcSEcCtD
Alitretinoin—Rash—Methylprednisolone—psoriatic arthritis	0.000205	0.000279	CcSEcCtD
Alitretinoin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000205	0.000279	CcSEcCtD
Alitretinoin—Urticaria—Prednisone—psoriatic arthritis	0.000205	0.000278	CcSEcCtD
Alitretinoin—Headache—Triamcinolone—psoriatic arthritis	0.000204	0.000278	CcSEcCtD
Alitretinoin—Headache—Methylprednisolone—psoriatic arthritis	0.000204	0.000277	CcSEcCtD
Alitretinoin—Abdominal pain—Prednisone—psoriatic arthritis	0.000204	0.000277	CcSEcCtD
Alitretinoin—Body temperature increased—Prednisone—psoriatic arthritis	0.000204	0.000277	CcSEcCtD
Alitretinoin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000202	0.000275	CcSEcCtD
Alitretinoin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000202	0.000275	CcSEcCtD
Alitretinoin—Hypotension—Methotrexate—psoriatic arthritis	0.000201	0.000274	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000196	0.000267	CcSEcCtD
Alitretinoin—Dizziness—Dexamethasone—psoriatic arthritis	0.000196	0.000266	CcSEcCtD
Alitretinoin—Dizziness—Betamethasone—psoriatic arthritis	0.000196	0.000266	CcSEcCtD
Alitretinoin—Insomnia—Methotrexate—psoriatic arthritis	0.000195	0.000265	CcSEcCtD
Alitretinoin—Nausea—Triamcinolone—psoriatic arthritis	0.000194	0.000263	CcSEcCtD
Alitretinoin—Paraesthesia—Methotrexate—psoriatic arthritis	0.000193	0.000263	CcSEcCtD
Alitretinoin—Nausea—Methylprednisolone—psoriatic arthritis	0.000193	0.000263	CcSEcCtD
Alitretinoin—Dyspnoea—Methotrexate—psoriatic arthritis	0.000192	0.000261	CcSEcCtD
Alitretinoin—Somnolence—Methotrexate—psoriatic arthritis	0.000191	0.00026	CcSEcCtD
Alitretinoin—Hypersensitivity—Prednisone—psoriatic arthritis	0.00019	0.000258	CcSEcCtD
Alitretinoin—Dyspepsia—Methotrexate—psoriatic arthritis	0.00019	0.000258	CcSEcCtD
Alitretinoin—Vomiting—Dexamethasone—psoriatic arthritis	0.000188	0.000256	CcSEcCtD
Alitretinoin—Vomiting—Betamethasone—psoriatic arthritis	0.000188	0.000256	CcSEcCtD
Alitretinoin—Decreased appetite—Methotrexate—psoriatic arthritis	0.000187	0.000255	CcSEcCtD
Alitretinoin—Rash—Dexamethasone—psoriatic arthritis	0.000187	0.000254	CcSEcCtD
Alitretinoin—Rash—Betamethasone—psoriatic arthritis	0.000187	0.000254	CcSEcCtD
Alitretinoin—Dermatitis—Betamethasone—psoriatic arthritis	0.000186	0.000253	CcSEcCtD
Alitretinoin—Dermatitis—Dexamethasone—psoriatic arthritis	0.000186	0.000253	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000186	0.000253	CcSEcCtD
Alitretinoin—Fatigue—Methotrexate—psoriatic arthritis	0.000186	0.000252	CcSEcCtD
Alitretinoin—Headache—Dexamethasone—psoriatic arthritis	0.000185	0.000252	CcSEcCtD
Alitretinoin—Headache—Betamethasone—psoriatic arthritis	0.000185	0.000252	CcSEcCtD
Alitretinoin—Asthenia—Prednisone—psoriatic arthritis	0.000185	0.000251	CcSEcCtD
Alitretinoin—Pain—Methotrexate—psoriatic arthritis	0.000184	0.00025	CcSEcCtD
Alitretinoin—Pruritus—Prednisone—psoriatic arthritis	0.000182	0.000248	CcSEcCtD
Alitretinoin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000177	0.000241	CcSEcCtD
Alitretinoin—Diarrhoea—Prednisone—psoriatic arthritis	0.000176	0.00024	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000176	0.000239	CcSEcCtD
Alitretinoin—Nausea—Dexamethasone—psoriatic arthritis	0.000176	0.000239	CcSEcCtD
Alitretinoin—Nausea—Betamethasone—psoriatic arthritis	0.000176	0.000239	CcSEcCtD
Alitretinoin—Urticaria—Methotrexate—psoriatic arthritis	0.000171	0.000233	CcSEcCtD
Alitretinoin—Dizziness—Prednisone—psoriatic arthritis	0.00017	0.000232	CcSEcCtD
Alitretinoin—Body temperature increased—Methotrexate—psoriatic arthritis	0.00017	0.000231	CcSEcCtD
Alitretinoin—Abdominal pain—Methotrexate—psoriatic arthritis	0.00017	0.000231	CcSEcCtD
Alitretinoin—Vomiting—Prednisone—psoriatic arthritis	0.000164	0.000223	CcSEcCtD
Alitretinoin—Rash—Prednisone—psoriatic arthritis	0.000162	0.000221	CcSEcCtD
Alitretinoin—Dermatitis—Prednisone—psoriatic arthritis	0.000162	0.000221	CcSEcCtD
Alitretinoin—Headache—Prednisone—psoriatic arthritis	0.000161	0.000219	CcSEcCtD
Alitretinoin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000159	0.000216	CcSEcCtD
Alitretinoin—Asthenia—Methotrexate—psoriatic arthritis	0.000154	0.00021	CcSEcCtD
Alitretinoin—Nausea—Prednisone—psoriatic arthritis	0.000153	0.000208	CcSEcCtD
Alitretinoin—Pruritus—Methotrexate—psoriatic arthritis	0.000152	0.000207	CcSEcCtD
Alitretinoin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000147	0.0002	CcSEcCtD
Alitretinoin—Dizziness—Methotrexate—psoriatic arthritis	0.000142	0.000194	CcSEcCtD
Alitretinoin—Vomiting—Methotrexate—psoriatic arthritis	0.000137	0.000186	CcSEcCtD
Alitretinoin—Rash—Methotrexate—psoriatic arthritis	0.000136	0.000185	CcSEcCtD
Alitretinoin—Dermatitis—Methotrexate—psoriatic arthritis	0.000136	0.000184	CcSEcCtD
Alitretinoin—Headache—Methotrexate—psoriatic arthritis	0.000135	0.000183	CcSEcCtD
Alitretinoin—Nausea—Methotrexate—psoriatic arthritis	0.000128	0.000174	CcSEcCtD
